Engineering of SauriCas9 with enhanced specificity
SauriCas9 is a compact Cas9 nuclease showing promise for in vivo therapeutic applications. However, concerns about off-target effects necessitated improvements in specificity. We addressed this by introducing mutations to eliminate polar contacts between Cas9 and the target DNA, resulting in the Sau...
Saved in:
Main Authors: | Xiaoqi Zhang, Chen Tao, Miaomiao Li, Sufang Zhang, Puping Liang, Yan Huang, Huihui Liu, Yongming Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253125000095 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas9: Role of genome editing in cancer immunotherapy
by: S. Vimal, et al.
Published: (2024-06-01) -
Genome editing using CRISPR/ Cas9 system: a practical guide
by: A. G. Menzorov, et al.
Published: (2017-02-01) -
Generation and propagation of high fecundity gene edited fine wool sheep by CRISPR/Cas9
by: Xuemei Zhang, et al.
Published: (2025-01-01) -
Intein-mediated split SaCas9 for genome editing in plants
by: Danling Hu, et al.
Published: (2025-01-01) -
Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene'ethic
by: Ayşenur Taşkaya, et al.
Published: (2023-10-01)